327 filings
ARS
2023 FY
EVOK
Evoke Pharma Inc
10 Apr 24
Annual report to shareholders
3:36pm
DEFA14A
EVOK
Evoke Pharma Inc
10 Apr 24
Additional proxy soliciting materials
3:35pm
DEF 14A
EVOK
Evoke Pharma Inc
Definitive proxy
10 Apr 24
3:34pm
PRE 14A
EVOK
Evoke Pharma Inc
Preliminary proxy
29 Mar 24
4:03pm
424B3
EVOK
Evoke Pharma Inc
25 Mar 24
Prospectus supplement
4:56pm
8-K
ok12y6ghboh 2ly94yi
25 Mar 24
Entry into a Material Definitive Agreement
4:55pm
8-K
8emm mhvkz
21 Mar 24
Departure of Directors or Certain Officers
4:15pm
8-K
oak7xa1
18 Mar 24
Other Events
5:02pm
POS EX
cmnhfssfyya0fryf79pw
14 Mar 24
Additional exhibits for listing
6:46pm
424B3
93m54re7f3t9 wf6hcj
14 Mar 24
Prospectus supplement
6:44pm
8-K
i11haj
14 Mar 24
Evoke Pharma Reports Fourth Quarter and Full Year 2023 Financial Results
4:00pm
8-K
od9wty5sy1wopzc 1q
23 Feb 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:15pm
8-K
4euc041 1xuu
14 Feb 24
Unregistered Sales of Equity Securities
9:00am
8-K
vv05oe rje6
9 Feb 24
Evoke Pharma Announces Pricing of Underwritten Public Offering of up to $30 Million
5:15pm
424B4
rudndje
9 Feb 24
Prospectus supplement with pricing info
5:14pm
EFFECT
xd85x5qcq3osp5
9 Feb 24
Notice of effectiveness
12:15am
CORRESP
s8fzotu44ifo2qiaa03
7 Feb 24
Correspondence with SEC
12:00am
CORRESP
t8jbs lwfn30a
7 Feb 24
Correspondence with SEC
12:00am